Garenoxacin Mesylate hydrate (BMS284756 (Mesylate hydrate)) |
Katalog-Nr.GC33950 |
Garenoxacin (BMS284756) Mesylathydrat ist ein oral wirksames Chinolon-Antibiotikum und hat ein breites Wirkungsspektrum gegen ein breites Spektrum grampositiver und gramnegativer Bakterien, Anaerobier und anspruchsvoller Organismen.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 223652-90-2
Sample solution is provided at 25 µL, 10mM.
Garenoxacin mesylate hydrate is a novel oral des-fluoro(6) quinolone with potent antimicrobial activity, against common respiratory pathogens, including resistant strains.
[1]. Waites KB, et al. In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob Agents Chemother. 2003 Jan;47(1):161-5. [2]. Ince D, et al. Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone. Antimicrob Agents Chemother. 2002 Nov;46(11):3370-80. [3]. Zhao X, et al. Mutant prevention concentration of garenoxacin (BMS-284756) for ciprofloxacin-susceptible or -resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2003 Mar;47(3):1023-7.
Average Rating: 5
(Based on Reviews and 8 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *